ELIZABETH ARDEN INC - 10-Q Quarterly Report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
[x]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2004

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________


Commission file number 1-6370

ELIZABETH ARDEN, INC.

(Exact name of registrant as specified in its charter)

Florida		59-0914138

(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

14100 N.W. 60th Avenue, Miami Lakes, Florida		33014

(Address of principal executive offices)		(Zip Code)

(305) 818-8000

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

Class		Outstanding at February 3, 2005

Common Stock, $.01 par value		28,577,669 shares

ELIZABETH ARDEN, INC.

INDEX TO FORM 10-Q

PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements	Page No.

	Unaudited Consolidated Balance Sheets - December 31, 2004 and June 30, 2004	3

	Unaudited Consolidated Statements of Operations - Three and six months ended December 31, 2004 and December 27, 2003	4

	Unaudited Consolidated Statement of Shareholders' Equity - Six months ended December 31, 2004	5

	Unaudited Consolidated Statements of Cash Flow - Six months ended December 31, 2004 and December 27, 2003	6

	Notes to Unaudited Consolidated Financial Statements	7

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	26

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35

Item 4.	Controls and Procedures	36

PART II	OTHER INFORMATION

Item 6.	Exhibits	37

Signatures		39

Exhibit Index		40

- 2 -

PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Dollars in thousands)

				As of

				December 31,			June 30,
				2004			2004

ASSETS
Current Assets
	Cash and cash equivalents			$	34,311		$	23,494
	Accounts receivable, net				197,974			102,306
	Inventories				259,709			258,638
	Deferred income taxes				4,351			16,723
	Prepaid expenses and other assets				14,964			15,914

			Total current assets		511,309			417,075


	Property and equipment, net				39,388			37,198


	Other Assets
		Exclusive brand licenses, trademarks and intangibles, net			188,059			191,842
		Debt financing costs, net			8,503			9,027
		Deferred income taxes and other			8,285			8,544


			Total other assets		204,847			209,413

			Total assets	$	755,544		$	663,686




LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
	Short-term debt			$	83,096		$	65,900
	Accounts payable - trade				111,982			106,375
	Other payables and accrued expenses				78,255			48,164
	Current portion of long-term debt				--			4,764

			Total current liabilities		273,333			225,203


	Long-term debt				233,802			233,802
	Other				3,090			2,621

			Total long-term liabilities		236,892			236,423

			Total liabilities		510,225			461,626

Commitments and contingencies (See Note 8)

Convertible, redeemable preferred stock, Series D, $.01 par value 559,873 shares authorized; no shares issued and outstanding					--			--

Shareholders' Equity
	Common stock, $.01 par value, 50,000,000 shares authorized; 28,514,054 and 28,169,941 shares issued and outstanding, respectively				285			282
	Additional paid-in capital				233,652			228,891
	Retained earnings (accumulated deficit)				14,452			(22,057	)
	Accumulated other comprehensive income				1,710			2,806
	Unearned deferred compensation				(4,780	)		(7,862	)

			Total shareholders' equity		245,319			202,060

			Total liabilities and shareholders' equity	$	755,544		$	663,686

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 3 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Amounts in thousands, except per share data)

			Three Months Ended				Six Months Ended

			December 31, 2004		December 27, 2003		December 31, 2004		December 27, 2003

Net sales			$	322,951	$	296,256	$	535,107	$	495,241
Cost of sales (excludes depreciation of $704, $937, $1,370, and $1,861, respectively, included below)				181,348		173,309		303,993		294,045

Gross profit				141,603		122,947		231,114		201,196

Operating expenses
	Selling, general and administrative			83,944		69,010		154,902		129,830
	Depreciation and amortization			5,449		5,373		10,982		10,485

		Total operating expenses		89,393		74,383		165,884		140,315

Income from operations				52,210		48,564		65,230		60,881


Other expense:
	Interest expense, net			6,274		9,377		12,259		19,851
	Debt extinguishment charges			--		9,446		--		9,446

		Other expense, net		6,274		18,823		12,259		29,297

Income before income taxes				45,936		29,741		52,971		31,584
Provision for income taxes				14,210		8,536		16,462		9,064

Net income				31,726		21,205		36,509		22,520
Accretion and dividend on preferred stock				--		695		--		1,698

Accelerated accretion on converted preferred stock				--		18,584		--		18,584

Net income attributable to common shareholders			$	31,726	$	1,926	$	36,509	$	2,238




Net income per common share (See Note 2):
	Basic		$	1.15	$	0.09	$	1.33	$	0.11




	Diluted		$	1.06	$	0.09	$	1.23	$	0.11




Weighted average number of common shares:
	Basic			27,519		22,166		27,430		20,283




	Diluted			29,888		22,166		29,743		20,283

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 4 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Unaudited)

(Amounts in thousands)

			Common Stock						Additional Paid-in Capital				Retained Earnings (Accumulated Deficit)				Accumulated Other Comprehensive Income				Unearned Deferred Compensation				Total Shareholders' Equity
			Shares			Amount

Balance at June 30, 2004		28,170			$		282	$		228,891		$		(22,057	)	$		2,806		$		(7,862	)	$		202,060

Issuance of common stock upon exercise of stock options		308					3			3,012																3,015

Issuance of common stock for employee stock purchase plan		46								810																810

Other										(71	)															(71	)

Forfeitures of restricted stock		(10		)						(84	)											84				-

Adjustment for mark to market accounting of performance- based restricted stock										519												(519	)			-

Amortization of unearned deferred compensation, net of forfeitures																						3,517				3,517

Tax benefit from exercise of stock options										575																575

Comprehensive income:
	Net income													36,509												36,509
	Foreign currency translations																	2,278								2,278
	Unrealized cash flow hedging loss, net of taxes																	(3,374	)							(3,374	)

Total comprehensive income		--					--			--				36,509				(1,096	)			--				35,413

Balance at December 31, 2004		28,514			$		285	$		233,652		$		14,452		$		1,710		$		(4,780	)	$		245,319

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 5 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
(Dollars in thousands)

					Six Months Ended

					December 31,			December 27,
					2004			2003

Operating Activities:
		Net income			$	36,509		$	22,520
		Adjustments to reconcile net income to net cash provided by operating activities:
			Depreciation and amortization			10,982			10,485
			Amortization of senior note offering costs and note premium			927			1,484
			Amortization of unearned deferred compensation			3,517			1,279
			Loss on redemption of senior notes			--			9,446
			Deferred income taxes			13,351			2,339
		Changes in assets and liabilities:
			Increase in accounts receivable			(95,668	)		(42,679	)
			(Increase) decrease in inventories			(1,071	)		50,480
			(Increase) decrease in prepaid expenses and other assets			(281	)		7,737
			Increase (decrease) in accounts payable			5,607			(24,359	)
			Increase in other payables, accrued expenses and other liabilities			27,186			21,931
			Other			1,333			772

				Net cash provided by operating activities		2,392			61,435


Investing Activities:
	Additions to property and equipment					(8,706	)		(7,611	)
	Proceeds from disposals of property and equipment					--			3
	Price adjustment to trademarks acquired in Arden acquisition					--			2,460

				Net cash used in investing activities		(8,706	)		(5,148	)


Financing Activities:
	Proceeds from (payments on) short-term debt					17,196			(12,727	)
	Payments on long-term debt					(4,764	)		(104,086	)
	Proceeds from the exercise of stock options					3,015			2,586
	Proceeds from the issuance of new common stock					--			62,668
	Proceeds from the issuance of common stock for employee stock purchase plan					810			--
	Repurchase of common stock					--			(398	)
	Other					(71	)		--

				Net cash provided by (used in) financing activities		16,186			(51,957	)

Effect of exchange rate changes on cash and cash equivalents						945			403
Net increase in cash and cash equivalents						10,817			4,733
Cash and cash equivalents at beginning of period						23,494			18,525

Cash and cash equivalents at end of period					$	34,311		$	23,258




Supplemental Disclosure of Cash Flow Information:
	Interest paid during the period				$	13,138		$	21,750



	Income taxes paid during the period				$	1,792		$	2,967

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 6 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. BUSINESS AND BASIS OF PRESENTATION

Elizabeth Arden, Inc. (the "Company") is a manufacturer and marketer of prestige designer fragrances, skin treatment and cosmetic products to retailers in the United States and approximately 90 countries internationally.

On June 2, 2004, the Company's board of directors (the "Board") approved a change in fiscal year end from January 31 to June 30, effective as of June 30, 2004. The change was implemented to better reflect the Company's business cycle and to enhance business planning relative to its customers' retail calendars. Accordingly, the financial statements are presented for the three and six month periods ended December 31, 2004, as compared to the three and six month periods ended December 27, 2003. The three and six month periods ended December 31, 2004 have one day more and two days more than the three and six month periods ended December 27, 2003, respectively.

The unaudited consolidated financial statements include the accounts of the Company's wholly-owned subsidiaries and all significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "Commission") for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation and should be read in conjunction with the audited consolidated financial statements and related footnotes included in the Company's Annual Report on Form 10-K for the year ended January 31, 2004 (the "Annual Report") and the Company's Transition Report on Form 10-Q for the five month transition period ended June 30, 2004 (the "Transition Report") filed with the Commission.

The consolidated balance sheet of the Company as of June 30, 2004 is derived from the financial statements included in the Company's Transition Report. The consolidated financial statements presented in this quarterly report are unaudited, but include all adjustments, which are of a normal recurring nature, that management considers necessary to fairly present the results for the interim periods. Results for interim periods are not necessarily indicative of results for the full fiscal year. Certain reclassifications were made to the prior years' consolidated financial statements and the accompanying footnotes.

NOTE 2. INCOME PER SHARE

Basic income per share is computed by dividing the net income attributable to common shareholders by the weighted average shares of outstanding common stock, $.01 par value per share ("Common Stock"). The calculation of diluted income per share is similar to basic income per share except that the denominator includes potentially dilutive Common Stock such as stock options, warrants and convertible securities. Diluted income per share equals basic income per share for the three and six month periods ended December 27, 2003 as the assumed conversion of convertible securities and the assumed exercise of outstanding options and warrants would have an anti-dilutive effect.

[Remainder of Page Intentionally Left Blank]

- 7 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The following table represents the computation of net income per share:

(Amounts in thousands, except per share data)

Three Months Ended

Six Months Ended

December 31, 2004

December 27, 2003

December 31, 2004

December 27, 2003

Basic
	Net income attributable to common shareholders		$	31,726	$	1,926	$	36,509	$	2,238



	Weighted average shares outstanding			27,519		22,166		27,430		20,283



	Net income per basic share		$	1.15	$	0.09	$	1.33	$	0.11



Diluted
	Net income attributable to common shareholders		$	31,726	$	1,926	$	36,509	$	2,238




	Weighted average shares outstanding			27,519		22,166		27,430		20,283

	Potential common shares - treasury method			2,369		--		2,313		--

	Weighted average shares and potential dilutive shares			29,888		22,166		29,743		20,283



		Net income per diluted share	$	1.06	$	0.09	$	1.23	$	0.11

For the three month period ended December 27, 2003, the calculation of diluted earnings per share excludes (a) 2.362 million potential common shares under the treasury method including unvested restricted stock awards; (b) 2.639 million shares of the Company's Series D Convertible Preferred Stock, $.01 par value ("Series D Convertible Preferred Stock") assumed to be converted as of the beginning of that fiscal year; and (c) 18,621 shares of Series D Convertible Preferred Stock that were received as a dividend and were convertible into 186,210 shares of Common Stock in the denominator and an add-back of $0.695 million to net income attributable to common shareholders related to non-accelerated accretion and dividends on the Series D Convertible Preferred Stock, and $18.584 million for the accelerated accretion charge associated with the conversion of certain Series D Convertible Preferred Stock, as such deductions and add-backs would have had an anti-dilu tive effect on the calculation of diluted earnings per share.

For the six month period ended December 27, 2003, the calculation of diluted earnings per share excludes (a) 2.196 million potential common shares under the treasury method including unvested restricted stock awards; (b) 3.403 million shares of the Company's Series D Convertible Preferred Stock, $.01 par value ("Series D Convertible Preferred Stock") assumed to be converted as of the beginning of that fiscal year; and (c) 18,621 shares of Series D Convertible Preferred Stock that were received as a dividend and were convertible into 186,210 shares of Common Stock in the denominator and an add-back of $1.698 million to net income attributable to common shareholders related to non-accelerated accretion and dividends on the Series D Convertible Preferred Stock, and $18.584 million for the accelerated accretion charge associated with the conversion of certain Series D Convertible Preferred Stock, as such deductions and add-backs would have had an anti-diluti ve effect on the calculation of diluted earnings per share.

The following table shows the options to purchase shares of Common Stock that were outstanding during the three and six months ended December 31, 2004 and December 27, 2003 where the option exercise price was greater than the average market price of the Common Stock over the applicable period:

	Three Months Ended				Six Months Ended

	December 31, 2004		December 27, 2003		December 31, 2004		December 27, 2003

Number of shares		--		24,000		--		124,000



Range of exercise price	$	--	$	20.15-20.64	$	--	$	18.16-20.64

- 8 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3. STOCK-BASED COMPENSATION

In December 2002, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standard ("SFAS") No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure - an Amendment of FASB Statement No. 123." This statement amends SFAS No. 123, "Accounting for Stock-Based Compensation," to provide alternative methods of transition for a voluntary change to the fair market value based method of accounting for stock-based employee compensation. In addition, this statement amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. For a discussion of Share-Based Payment ("SFAS 123R"), see Note 4.

The Company accounts for its stock incentive plans under the recognition and measurement principles prescribed by Accounting Principles Board Opinion ("APB") No. 25, "Accounting for Stock Issued to Employees," and related interpretations, under which no compensation costs are required to be recognized for the periods presented. No employee stock-option compensation cost is reflected in net income, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net income attributable to common shareholders and net income per common share if the Company had applied the fair value recognition provisions of SFAS No. 123, "Accounting for Stock-Based Compensation," to stock option compensation:

(Amounts in thousands, except per share data)

Three Months Ended

Six Months Ended

December 31, 2004

December 27, 2003

December 31, 2004

December 27, 2003

Net income attributable to common shareholders, as reported		$	31,726	$	1,926	$	36,509	$	2,238
Add: Restricted stock-based employee compensation costs, net of tax, currently included in net income			1,310		420		2,392		912
Less: Stock-based employee compensation expense, net of tax, determined under fair value-based method			2,197		1,745		4,165		3,519

Pro forma net income (loss) attributable to common shareholders		$	30,839	$	601	$	34,736	$	(369	)



Net income (loss) per common share
Basic
	As reported	$	1.15	$	0.09	$	1.33	$	0.11
	Pro forma	$	1.12	$	0.03	$	1.27	$	(0.02	)
Diluted
	As reported	$	1.06	$	0.09	$	1.23	$	0.11
	Pro forma	$	1.03	$	0.03	$	1.17	$	(0.02	)

- 9 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS AND RECENT LEGISLATION

In December 2004, the FASB issued its final standard on accounting for share-based payments (SBP), FASB Statement No.123R (revised 2004), (SFAS 123R) which requires companies to expense the value of employee stock options and similar awards. Under SFAS 123R, SBP awards result in a cost that will be measured at fair value on the awards grant date, based on the estimated number of awards that are expected to vest. Compensation cost for awards that vest would not be reversed if the awards expire without being exercised. The effective date for public companies is interim and annual periods beginning after June 15, 2005, and applies to all outstanding and unvested SBP awards at a company's adoption date. Therefore, SFAS 123R will affect the Company beginning in the three month period ending September 30, 2005. The Company is evaluating the impact that SFAS 123R will have on compensation expense for future periods.

In October 2004, the American Jobs Creation Act of 2004 (the "Act") was signed into law. The Act contains a number of provisions that might affect the Company's future effective tax rate. The most significant provision would allow the Company to elect to deduct from its taxable income 85% of certain eligible dividends received by the Company from non-U.S. subsidiaries before the end of 2005 if those dividends are reinvested in the U.S. for eligible purposes. Another significant provision replaces the extraterritorial income exclusion (ETI) with a domestic manufacturing deduction. To the extent the Company remits eligible dividends, it would have to record a provision for U.S. federal and state income taxes on the taxable portion of the remittance as no taxes have been previously provided. The Company is evaluating the impact the Act will have on its effective tax rate for this fiscal year and beyond.

NOTE 5. INVENTORIES

The components of inventory were as follows:

	December 31,		June 30,
(Dollars in thousands)	2004		2004

Raw materials	$	45,257	$	49,373
Work in progress	20,004		35,938
Finished goods	194,448		173,327

Total	$	259,709	$	258,638

NOTE 6. SHORT-TERM DEBT

The Company has a revolving credit facility with a syndicate of banks, for which JP Morgan Chase Bank is the administrative agent, that provides for borrowings on a revolving basis of up to $200 million with a $25 million sublimit for letters of credit (the "Credit Facility"). The Company entered into an amendment to the Credit Facility effective September 30, 2004 that extended the maturity of the Credit Facility to June 2009 from January 2006, reduced the interest rates and commitment fees based on the Company's debt service coverage ratio and enhanced the inventory component of the borrowing base. The Credit Facility is guaranteed by all of the Company's U.S. subsidiaries. Borrowings under the Credit Facility are limited to 85% of eligible accounts receivable and 75% (65% from November 16 through May 15) of eligible finished goods inventory and are collateralized by a first priority lien on all of the Company's U.S. accounts receivable an d inventory. The Company's obligations under the Credit Facility rank pari passu, or equal in right of payment, with the Company's remaining 11 3/4% Senior Secured Notes due 2011(the "11 3/4% Senior Notes") and rank senior to the Company's 7 3/4% Senior Subordinated Notes due 2014 (the "7 3/4% Senior Subordinated Notes").

The Credit Facility has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if average borrowing availability declines to less than $25 million ($40 million from November 16 through May 15). No financial maintenance covenant was applicable for the three and six month periods ended December 31, 2004. The Credit Facility restricts the Company from incurring additional non-trade indebtedness (other than refinancing and certain small amounts of indebtedness) and limits the payment of dividends on the Company's Common Stock, repurchases of Common Stock and other distributions to common shareholders.

- 10 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Borrowings under the revolving credit portion of the Credit Facility bear interest at a floating rate based on the "Applicable Margin," which is determined by reference to a specific financial ratio. At the Company's option, the Applicable Margin may be applied to either the London InterBank Offered Rate ("LIBOR") or the prime rate. The reference ratio for determining the Applicable Margin is a debt service coverage ratio. As a result of the September 2004 amendment to the Credit Facility, the interest rates charged on LIBOR loans and prime rate loans were reduced to a range of 1.50% to 2.25% from a range of 2.00% to 2.75% for LIBOR loans and to a range of 0% to .50% from a range of 0.25% to 1.00% for prime rate borrowings. As of December 31, 2004, the Applicable Margin was 1.50% for LIBOR loans and 0% for prime rate loans. The commitment fee on the unused portion of the Credit Facility ranges from 0.25% to 0.375% per year. At December 31, 2004, the comm itment fee was 0.30%.

As of December 31, 2004, the Company had approximately $83 million in outstanding borrowings under the Credit Facility, as compared with approximately $66 million in outstanding borrowings under the Credit Facility at June 30, 2004. As of December 31, 2004, the Company had approximately $167 million of eligible receivables and inventories available as collateral under the Credit Facility. Therefore, the Company had availability of approximately $84 million. The Company classifies the Credit Facility as short-term debt on its balance sheet since it expects to reduce outstanding borrowings during the third quarter (January through March) of its fiscal year.

NOTE 7. LONG-TERM DEBT

The Company's long-term debt consisted of the following:

(Dollars in thousands)	December 31,		June 30,
Description	2004		2004

11 3/4% Senior Secured Notes due May 2011	$	8,802	$	8,802
7 3/4% Senior Subordinated Notes due January 2014		225,000		225,000
8.84% Miami Lakes Facility Mortgage Note due July 2004		--		4,764

Total		233,802		238,566
Less: Current portion of long-term debt		--		4,764

Long-term debt, net	$	233,802	$	233,802

On July 1, 2004, the Company paid the remaining balance of $4.8 million plus accrued interest on the 8.84% Miami Lakes Facility Mortgage Note due July 2004.

The following table lists all redemptions of 11 3/4% Senior Notes and 10 3/8% Senior Notes during the three and six month periods ended December 27, 2003 and the related financial statement effect.

(Dollars in thousands)

Redemption Date	Debt Instrument		Redemption Price		Principal Repurchased		Call Premium (Discount)		Write-off of offering Costs		Excess of Carrying Value Over Principal Repurchased			Total (Gain) Loss⁽¹⁾

10/24/03	10 3/8	%	103.458	%	$	20,000	$	692	$	252	$	(654	)	$	290
11/21/03	11 3/4	%	111.75	%		56,000		6,580		2,101		--			8,681
12/17/03	10 3/8	%	103.458	%		20,000		691		237		(453	)		475

					$	96,000	$	7,963	$	2,590	$	(1,107	)	$	9,446

(1) Loss refers to debt extinguishment charges included in the Company's Consolidated Statements of Operations.

- 11 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8. COMMITMENTS AND CONTINGENCIES

At December 31, 2004, the Company had commitments to incur promotional and advertising expenses, which are either fixed commitments or based on net sales for licensed brands, and minimum royalty guarantees in an aggregate amount of $10.3 million through 2009 compared with $33.5 million as previously stated in the Company's Transition Report at June 30, 2004.

In February 2004, the Company entered into an interest rate swap agreement to swap $50.0 million of the outstanding 7 3/4% Senior Subordinated Notes to a floating interest rate based on LIBOR. In the short term, this will provide the Company with a lower level of interest expense related to a portion of the 7 3/4% senior subordinated notes based on current LIBOR rates; however, over the life of the notes, interest expense may be greater than 7 3/4% based upon fluctuations in LIBOR. The swap agreement matures in February 2014. The Company can terminate the swap agreement at its option at any time and the counter party can call the swap agreement any time after January 2009. The Company has designated the swap agreement as a fair value hedge.

As of December 31, 2004, the Company had notional amounts of 40.6 million Euros and 10.4 million British pounds under foreign currency contracts that expire between January 31, 2005 and June 30, 2007 to reduce the exposure of its foreign subsidiary revenues to fluctuations in currency rates. The Company has designated each foreign currency option contract as a cash flow hedge. The unrealized loss, net of taxes, at December 31, 2004 associated with these contracts of approximately $3.3 million is included in accumulated other comprehensive income. The unrealized loss, net of taxes, incurred during the six months ended December 31, 2004 was approximately $3.4 million.

The Company is a party to a number of other legal actions, proceedings or claims. While any action, proceeding or claim contains an element of uncertainty management of the Company believes that the outcome of such actions, proceedings or claims will not have a material adverse effect on the Company's business, financial position or results of operations.

NOTE 9. CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY

Equity Offering. On October 22, 2003, the Company completed a public offering of 5,750,000 shares of Common Stock at $18.25 per share. The Company sold 3,666,667 shares of Common Stock in the offering, and an affiliate of Unilever sold 2,083,333 shares. The gross proceeds, before the offering discount of $3.8 million and approximately $0.4 million of offering expenses, was approximately $66.9 million, resulting in net proceeds to the Company of approximately $62.7 million. The Company used the net proceeds on November 21, 2003 to redeem $56 million aggregate principal amount of the 11 3/4% Senior Notes. See Note 7. The Company did not receive any proceeds from the sale of the shares by the affiliate of Unilever.

Conversion of Preferred Stock. In connection with the public offering of Common Stock on October 22, 2003, an affiliate of Unilever converted 208,340 shares (representing $25 million of aggregate liquidation preference) of the Company's Series D Convertible Preferred Stock into 2,083,340 shares of Common Stock. As a result of the conversion of the Series D Convertible Preferred Stock, the accretion of the Series D Convertible Preferred Stock converted was accelerated in the amount of $18.6 million, resulting in a non-cash charge in this amount to net income attributable to common shareholders on the Company's consolidated statements of operations for the three months ended December 27, 2003.

Convertible Preferred Stock

At January 31, 2004, the Company had outstanding 226,955 shares $120 per share liquidation preference, of Series D Convertible Preferred Stock that was issued to an affiliate of Unilever in connection with the January 2001 acquisition of the Elizabeth Arden business. Each share of Series D Convertible Preferred Stock was fully convertible into 10 shares of Common Stock at an initial conversion price of $12 per share of Common Stock, subject to certain restrictions, since January 23, 2004. In addition, cumulative dividends of 5% of the outstanding liquidation preference of the Series D Convertible Preferred Stock began to accrue on January 23, 2003 and were payable quarterly in additional shares of Series D Convertible Preferred Stock.

- 12 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

In June 2004, the affiliate of Unilever converted the remaining 231,793 shares of Series D Convertible Preferred Stock, (representing approximately $28.8 million of aggregate liquidation preference) into 2,317,930 shares of Common Stock, which were sold in a public offering on June 15, 2004. As a result of the conversion, the Company recorded accelerated accretion charges in June 2004 and there will be no additional accretion and dividend charges relating to the Series D Convertible Preferred Stock.

Upon issuance, the Series D Convertible Preferred Stock was recorded at its fair market value of $35 million, with an allocation of $26.5 million made for the beneficial conversion feature and reclassified to additional paid-in capital. The accretion of the beneficial conversion feature was based on the effective yield method over the period from issue date to the mandatory redemption date (12 years). The recorded dividend was based on the straight-line method, which approximates the effective yield method, with the total amount of the dividend of $25 million to be paid over 10 years amortized over the period from issue date to the mandatory redemption date (12 years) or $2.1 million annually. The difference between the liquidation value of $50 million and the $8.5 million balance recorded in Series D Convertible Preferred Stock on the Company's consolidated balance sheet upon their issuance was being accreted over the life of the Series D Convertible Pr eferred Stock.

The following table sets forth the accretion and dividend on the Series D Convertible Preferred Stock for the three and six month periods ended December 27, 2003:

(Dollars in thousands)	Three Months Ended		Six Months Ended

	December 27, 2003		December 27, 2003

Aggregate accretion	$	321	$	776
Dividends	374		922

Total	$	695	$	1,698

Stock Incentive Plans and Awards

At December 31, 2004, the Company had five stock incentive plans, two for the benefit of non-employee directors (the 1995 Non-Employee Director Plan and the 2004 Non-Employee Director Plan (the "2004 Director Plan")) and three for the benefit of eligible employees and independent contractors (the 1995 Stock Option Plan, the 2000 Stock Incentive Plan and the 2004 Stock Incentive Plan (the "2004 Incentive Plan")). All five plans were adopted by the Board and approved by the Company's shareholders. The shareholders of the Company approved the 2004 Incentive Plan on June 22, 2004, as there remained no shares of Common Stock available for grant under the 1995 Stock Option Plan and the 2000 Stock Incentive Plan. The 2004 Director Plan was also approved by the shareholders of the Company on June 22, 2004 and replaced the 1995 Non-Employee Director Plan. No further grants of stock options will occur under the 1995 Non-Employee Director Plan.

The 2004 Director Plan authorizes the Company to grant non-qualified stock options for 350,000 shares of Common Stock under such plan to non-employee directors of the Company. Each year on the date of the annual meeting of the shareholders and provided that a sufficient number of shares remain available under the 2004 Director Plan, there will automatically be granted to each eligible director who is re-elected to the Board an option to purchase 7,000 shares of Common Stock or such other amount as the Board determines based on a competitive review of comparable companies. Unless service is terminated due to death, disability or retirement in good standing after age 70, each option granted under the 2004 Director Plan on an annual shareholder meeting date will become exercisable three years from the date of grant if such person has continued to serve as a director until that date. No option may be exercisable after the expiration of ten years from the date of grant. The exercise price will represent the closing price of the Common Stock on the date of grant. At December 31, 2004, 315,000 shares of Common Stock remained available for grant under the 2004 Non-Employee Director Plan.

- 13 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The 2004 Incentive Plan authorizes the Company to grant stock-based incentives for 2,000,000 shares of Common Stock under such plan to eligible employees and others that provide services to the Company. The stock options awarded under the 2004 Incentive Plan are exercisable at any time or in any installments as determined by the compensation committee of the Board at the time of grant and may be either incentive or non-qualified stock options under the Internal Revenue Code, as determined by the compensation committee. The exercise price for stock option grants will represent the closing price of the Common Stock on the date of grant. The 2004 Incentive Plan also permits stock appreciation rights, stock awards, performance awards and stock units. At December 31, 2004, no stock-based incentives have been granted and, therefore, all shares remain available for grant under the 2004 Incentive Plan.

The Company currently has an Employee Stock Purchase Plan ("ESPP") under which employees in certain countries are permitted to deposit after tax funds from their wages for purposes of purchasing Common Stock at a 15% discount from the lowest of the closing price of the Common Stock at either the start of the contribution period or the end of the contribution period. On December 31, 2004 there were 46,067 shares purchased under the ESPP. The next purchase under the ESPP will be consummated on June 1, 2005.

NOTE 10. CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The following condensed financial statements as of December 31, 2004 and for the three and six month periods then ended, and as of June 30, 2004, show the consolidated financial statements of the Company, and, in separate financial statements, (i) the financial statements of those subsidiaries that are guarantors of the 7 3/4% Senior Subordinated Notes issued in January 2004, plus, in each case, the financial statements of non-guarantor entities, elimination adjustments and the consolidated total, and (ii) the financial statements of those subsidiaries that are guarantors of the 11 3/4% Senior Notes which were issued in January 2001 to finance a portion of the purchase price for the acquisition of the Elizabeth Arden business plus, in each case, the financial statements of non-guarantor entities, elimination adjustments and the consolidated total. The following condensed financial statements for the three and six month periods ended December 27, 2003, s how the consolidated financial statements of the Company and the financial statements of those subsidiaries that are guarantors of the 11 3/4% Senior Notes. The Company's subsidiaries, DF Enterprises, Inc., FD Management, Inc., Elizabeth Arden International Holding, Inc. and Elizabeth Arden (Zug) GmbH, are guarantors of the 11 3/4% Senior Notes. DF Enterprises, Inc., FD Management, Inc., Elizabeth Arden International Holding, Inc., Elizabeth Arden (Financing), Inc., RDEN Management, Inc. and Elizabeth Arden Travel Retail, Inc. are guarantors of the 7 3/4% Senior Subordinated Notes. Equity income of the guarantor subsidiaries is included in other (expense) income, net. All subsidiaries listed in this note are wholly-owned subsidiaries of the Company and their guarantees are joint and several, full and unconditional. All information presented is in thousands.

[Remainder of Page Intentionally Left Blank]

- 14 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Balance Sheet				As of December 31, 2004

					Company			Non- Guarantors			7 3/4% Senior Subordinated Notes Guarantors		Eliminations			Total

ASSETS
Current Assets
	Cash and cash equivalents				$	8,432		$	25,777		$	102	$	--		$	34,311
	Accounts receivable, net					114,441			83,533			--		--			197,974
	Inventories					176,444			83,265			--		--			259,709
	Intercompany receivable					76,347			104,400			421,741		(602,488	)		--
	Deferred income taxes					4,351			--			--		--			4,351
	Prepaid expenses and other assets					4,120			10,839			5		--			14,964

			Total current assets			384,135			307,814			421,848		(602,488	)		511,309


Property and equipment, net						27,384			12,004			--		--			39,388

Other Assets:
	Investment in subsidiaries					42,795			--			--		(42,795	)		--
	Exclusive brand licenses, trademarks and intangibles, net					21,470			5,535			161,054		--			188,059
	Debt financing costs, net					8,503			--			--		--			8,503
	Other assets					276,347			(277,198	)		9,136		--			8,285

		Total other assets				349,115			(271,663	)		170,190		(42,795	)		204,847

		Total assets			$	760,634		$	48,155		$	592,038	$	(645,283	)	$	755,544




LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
	Short-term debt				$	83,096		$	--		$	--	$	--		$	83,096
	Accounts payable - trade					93,860			18,122			--		--			111,982
	Intercompany payable					58,968			231,031			312,489		(602,488	)		--
	Other payables and accrued expenses					43,482			33,029			1,744		--			78,255

			Total current liabilities			279,406			282,182			314,233		(602,488	)		273,333


	Long-term debt, net					233,802			--			--		--			233,802
	Other					2,107			983			--		--			3,090

			Total liabilities			515,315			283,165			314,233		(602,488	)		510,225


Shareholders' Equity
	Common stock					285			--			--		--			285
	Additional paid-in capital					233,652			(269,164	)		269,164		--			233,652
	Retained earnings					14,452			32,322			8,641		(40,963	)		14,452
	Accumulated other comprehensive income					1,710			1,832			--		(1,832	)		1,710
	Unearned deferred compensation					(4,780	)		--			--		--			(4,780	)

			Total shareholders' equity			245,319			(235,010	)		277,805		(42,795	)		245,319

			Total liabilities and shareholders' equity		$	760,634		$	48,155		$	592,038	$	(645,283	)	$	755,544

- 15 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Balance Sheet			As of December 31, 2004

				Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

ASSETS
Current Assets
	Cash and cash equivalents			$	8,432		$	25,833		$	46		$	--		$	34,311
	Accounts receivable, net				114,441			83,533			--			--			197,974
	Inventories				176,444			83,265			--			--			259,709
	Intercompany receivable				76,347			407,392			118,749			(602,488	)		--
	Deferred income taxes				4,351			--			--			--			4,351
	Prepaid expenses and other assets				4,120			10,767			77			--			14,964

		Total current assets			384,135			610,790			118,872			(602,488	)		511,309


Property and equipment, net					27,384			12,004			--			--			39,388

Other Assets:
	Investment in subsidiaries				42,795			--			--			(42,795	)		--
	Exclusive brand licenses, trademarks and intangibles, net				21,470			84			166,505			--			188,059
	Debt financing costs, net				8,503			--			--			--			8,503
	Other assets				276,347			(277,198	)		9,136			--			8,285

		Total other assets			349,115			(277,114	)		175,641			(42,795	)		204,847

		Total assets		$	760,634		$	345,680		$	294,513		$	(645,283	)	$	755,544




LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
	Short-term debt			$	83,096		$	--		$	--		$	--		$	83,096
	Accounts payable - trade				93,860			18,122			--			--			111,982
	Intercompany payable				58,968			223,105			320,415			(602,488	)		--
	Other payables and accrued expenses				43,482			33,029			1,744			--			78,255

		Total current liabilities			279,406			274,256			322,159			(602,488	)		273,333


	Long-term debt, net				233,802			--			--			--			233,802
	Other				2,107			983			--			--			3,090

		Total liabilities			515,315			275,239			322,159			(602,488	)		510,225


Shareholders' Equity
	Common stock				285			--			--			--			285
	Additional paid-in capital				233,652			(44	)		44			--			233,652
	Retained earnings				14,452			68,662			(27,699	)		(40,963	)		14,452
	Accumulated other comprehensive income				1,710			1,823			9			(1,832	)		1,710
	Unearned deferred compensation				(4,780	)		--			--			--			(4,780	)

		Total shareholders' equity			245,319			70,441			(27,646	)		(42,795	)		245,319

		Total liabilities and shareholders' equity		$	760,634		$	345,680		$	294,513		$	(645,283	)	$	755,544

- 16 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Balance Sheet				As of June 30, 2004

					Company			Non- Guarantors			7 3/4% Senior Subordinated Notes Guarantors		Eliminations			Total

ASSETS
Current Assets
		Cash and cash equivalents			$	7,251		$	16,202		$	41	$	--		$	23,494
		Accounts receivable, net				54,270			48,036			--		--			102,306
		Inventories				187,359			71,279			--		--			258,638
		Intercompany receivable				56,500			74,526			398,749		(529,775	)		--
		Deferred income taxes				16,723			--			--		--			16,723
		Prepaid expenses and other assets				5,018			10,859			37		--			15,914

			Total current assets			327,121			220,902			398,827		(529,775	)		417,075


Property and equipment, net						27,125			10,073			--		--			37,198

Other Assets:
	Investment in subsidiaries					19,908			--			--		(19,908	)		--
	Exclusive brand licenses, trademarks and intangibles, net					24,390			5,553			161,899		--			191,842
	Debt financing costs, net					9,027			--			--		--			9,027
	Deferred income taxes and other					271,827			(268,417	)		5,134		--			8,544

			Total other assets			325,152			(262,864	)		167,033		(19,908	)		209,413

			Total assets		$	679,398		$	(31,889	)	$	565,860	$	(549,683	)	$	663,686




LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
	Short-term debt				$	65,900		$	--		$	--	$	--		$	65,900
	Accounts payable - trade					93,173			13,202			--		--			106,375
	Intercompany payable					51,365			181,060			297,354		(529,779	)		--
	Other payables and accrued expenses					26,594			21,147			419		4			48,164
	Current portion of long-term debt					4,764			--			--		--			4,764

			Total current liabilities			241,796			215,409			297,773		(529,775	)		225,203


	Long-term debt, net					233,802			--			--		--			233,802
	Other					1,740			881			--		--			2,621

			Total liabilities			477,338			216,290			297,773		(529,775	)		461,626


Shareholders' Equity
	Common stock					282			--			--		--			282
	Additional paid-in capital					228,891			(265,164	)		265,164		--			228,891
	(Accumulated deficit) retained earnings					(22,057	)		14,058			2,923		(16,981	)		(22,057	)
	Accumulated other comprehensive income					2,806			2,927			--		(2,927	)		2,806
	Unearned deferred compensation					(7,862	)		--			--		--			(7,862	)

			Total shareholders' equity			202,060			(248,179	)		268,087		(19,908	)		202,060

			Total liabilities and shareholders' equity		$	679,398		$	(31,889	)	$	565,860	$	(549,683	)	$	663,686

- 17 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Balance Sheet			As of June 30, 2004

				Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

ASSETS
Current Assets
	Cash and cash equivalents			$	7,251		$	16,213		$	30		$	--		$	23,494
	Accounts receivable, net				54,270			48,036			--			--			102,306
	Inventories				187,359			71,279			--			--			258,638
	Intercompany receivable				56,500			365,781			107,494			(529,775	)		--
	Deferred income taxes				16,723			--			--			--			16,723
	Prepaid expenses and other assets				5,018			10,776			120			--			15,914

		Total current assets			327,121			512,085			107,644			(529,775	)		417,075


Property and equipment, net					27,125			10,073			--			--			37,198

Other Assets:
	Investment in subsidiaries				19,908			--			--			(19,908	)		--
	Exclusive brand licenses, trademarks and intangibles, net				24,390			98			167,354			--			191,842
	Debt financing costs, net				9,027			--			--			--			9,027
	Deferred income taxes and other				271,827			(268,419	)		5,136			--			8,544

		Total other assets			325,152			(268,321	)		172,490			(19,908	)		209,413

		Total assets		$	679,398		$	253,837		$	280,134		$	(549,683	)	$	663,686




LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
	Short-term debt			$	65,900		$	--		$	--		$	--		$	65,900
	Accounts payable - trade				93,173			13,202			--			--			106,375
	Intercompany payable				51,365			173,821			304,593			(529,779	)		--
	Other payables and accrued expenses				26,594			21,147			419			4			48,164
	Current portion of long-term debt				4,764			--			--			--			4,764

		Total current liabilities			241,796			208,170			305,012			(529,775	)		225,203


	Long-term debt, net				233,802			--			--			--			233,802
	Other				1,740			881			--			--			2,621

		Total liabilities			477,338			209,051			305,012			(529,775	)		461,626


Shareholders' Equity
	Common stock				282			--			--			--			282
	Additional paid-in capital				228,891			(44	)		44			--			228,891
	(Accumulated deficit) retained earnings				(22,057	)		41,912			(24,931	)		(16,981	)		(22,057	)
	Accumulated other comprehensive income				2,806			2,918			9			(2,927	)		2,806
	Unearned deferred compensation				(7,862	)		--			--			--			(7,862	)

		Total shareholders' equity			202,060			44,786			(24,878	)		(19,908	)		202,060

		Total liabilities and shareholders' equity		$	679,398		$	253,837		$	280,134		$	(549,683	)	$	663,686

- 18 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Statement of Operations		Three Months Ended December 31, 2004

			Company			Non- Guarantors		7 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	218,078		$	104,873	$	5,391		$	(5,391	)	$	322,951
Cost of sales				135,571			45,777		--			--			181,348

Gross profit				82,507			59,096		5,391			(5,391	)		141,603


Selling, general and administrative costs				50,711			39,033		(409	)		(5,391	)		83,944
Depreciation and amortization				3,316			1,457		676			--			5,449

Income from operations				28,480			18,606		5,124			--			52,210
Other expense (income):
	Interest expense (income)			6,249			707		(682	)		--			6,274
	Other			(20,420	)		87		2,597			17,736			--

Income before income taxes				42,651			17,812		3,209			(17,736	)		45,936
Provision for income taxes				10,925			3,285		--			--			14,210

Net income			$	31,726		$	14,527	$	3,209		$	(17,736	)	$	31,726

Statement of Operations		Six Months Ended December 31, 2004

			Company			Non- Guarantors		7 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	355,890		$	179,217	$	8,988		$	(8,988	)	$	535,107
Cost of sales				224,574			79,419		--			--			303,993

Gross profit				131,316			99,798		8,988			(8,988	)		231,114


Selling, general and administrative costs				91,753			72,961		(824	)		(8,988	)		154,902
Depreciation and amortization				6,662			2,963		1,357			--			10,982

Income from operations				32,901			23,874		8,455			--			65,230
Other expense (income):
	Interest expense (income)			12,227			1,385		(1,353	)		--			12,259
	Other			(28,296	)		223		4,093			23,980			-

Income before income taxes				48,970			22,266		5,715			(23,980	)		52,971
Provision for income taxes				12,461			4,001		--			--			16,462

Net (loss) income			$	36,509		$	18,265	$	5,715		$	(23,980	)	$	36,509

- 19 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Statement of Operations		Three Months Ended December 31, 2004

			Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	218,078		$	104,873		$	5,391		$	(5,391	)	$	322,951
Cost of sales				135,571			45,777			--			--			181,348

Gross profit				82,507			59,096			5,391			(5,391	)		141,603


Selling, general and administrative costs				50,711			38,987			(363	)		(5,391	)		83,944
Depreciation and amortization				3,316			1,456			677			--			5,449

Income from operations				28,480			18,653			5,077			--			52,210
Other expense (income):
	Interest expense (income)			6,249			(3,497	)		3,522			--			6,274
	Other			(20,420	)		87			2,597			17,736			--

Income (loss) before income taxes				42,651			22,063			(1,042	)		(17,736	)		45,936
Provision for income taxes				10,925			3,285			--			--			14,210

Net income (loss)			$	31,726		$	18,778		$	(1,042	)	$	(17,736	)	$	31,726

Statement of Operations		Six Months Ended December 31, 2004

			Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	355,890		$	179,217		$	8,988		$	(8,988	)	$	535,107
Cost of sales				224,574			79,419			--			--			303,993

Gross profit				131,316			99,798			8,988			(8,988	)		231,114


Selling, general and administrative costs				91,753			72,911			(774	)		(8,988	)		154,902
Depreciation and amortization				6,662			2,960			1,360			--			10,982

Income from operations				32,901			23,927			8,402			--			65,230
Other expense (income):
	Interest expense (income)			12,227			(7,046	)		7,078			--			12,259
	Other			(28,296	)		223			4,093			23,980			--

Income (loss) before income taxes				48,970			30,750			(2,769	)		(23,980	)		52,971
Provision for income taxes				12,461			4,001			--			--			16,462

Net (loss) income			$	36,509		$	26,749		$	(2,769	)	$	(23,980	)	$	36,509

- 20 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Statement of Operations		Three Months Ended December 27, 2003

			Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	204,711		$	91,545		$	5,682		$	(5,682	)	$	296,256
Cost of sales				130,998			42,311			--			--			173,309

Gross profit				73,713			49,234			5,682			(5,682	)		122,947


Selling, general and administrative costs				42,762			32,300			(370	)		(5,682	)		69,010
Depreciation and amortization				3,210			1,574			589			--			5,373

Income from operations				27,741			15,360			5,463			--			48,564
Other expense (income):
	Interest expense (income)			9,359			(5,388	)		5,406			--			9,377
	Debt extinguishment charges			9,446			--			--			--			9,446
	Other			(18,121	)		(463	)		2,584			16,000			--

Income (loss) before income taxes				27,057			21,211			(2,527	)		(16,000	)		29,741
Provision for (benefit from) income taxes				5,852			2,716			(32	)		--			8,536

Net income (loss)			$	21,205		$	18,495		$	(2,495	)	$	(16,000	)	$	21,205

Statement of Operations		Six Months Ended December 27, 2003

			Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Net sales			$	341,945		$	153,296		$	9,957		$	(9,957	)	$	495,241
Cost of sales				223,310			70,735			--			--			294,045

Gross profit				118,635			82,561			9,957			(9,957	)		201,196


Selling, general and administrative costs				79,603			61,333			(1,149	)		(9,957	)		129,830
Depreciation and amortization				6,401			2,948			1,136			--			10,485

Income from operations				32,631			18,280			9,970			--			60,881
Other expense (income):
	Interest expense (income)			19,808			(10,770	)		10,813			--			19,851
	Debt extinguishment charges			9,446			--			--			--			9,446
	Other			(24,687	)		(754	)		4,296			21,145			--

Income (loss) before income taxes				28,064			29,804			(5,139	)		(21,145	)		31,584
Provision for (benefit from) income taxes				5,544			3,587			(67	)		--			9,064

Net income (loss)			$	22,520		$	26,217		$	(5,072	)	$	(21,145	)	$	22,520

- 21 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Statement of Cash Flows		Six Months Ended December 31, 2004

			Company			Non- Guarantors			7 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Operating activities:
Net cash provided by (used in) operating activities			$	150		$	(5,672	)	$	7,918		$	(4	)	$	2,392


Investing activities:
	Additions to property and equipment			(3,856	)		(4,850	)		--			--			(8,706	)

Net cash used in investing activities				(3,856	)		(4,850	)		--			--			(8,706	)


Financing activities:
	Proceeds from short-term debt			17,196			--			--			--			17,196
	Payments on long-term debt			(4,764	)		--			--			--			(4,764	)
	Proceeds from the exercise of stock options			3,015			--			--			--			3,015
	Proceeds from issuance of common stock for employee stock purchase plan			810			--			--			--			810
	Other			(71	)		--			--			--			(71	)
	Net change in intercompany obligations			(12,244	)		20,097			(7,857	)		4			--

Net cash provided by (used in) financing activities				3,942			20,097			(7,857	)		4			16,186

Effect of exchange rate changes on cash and cash equivalents				945			--			--			--			945
Net increase in cash and cash equivalents				1,181			9,575			61			--			10,817
Cash and cash equivalents at beginning of period				7,251			16,202			41			--			23,494

Cash and cash equivalents at end of period			$	8,432		$	25,777		$	102		$	--		$	34,311

Statement of Cash Flows		Six Months Ended December 31, 2004

			Company			Non- Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Operating activities:
Net cash provided by (used in) operating activities			$	150		$	6,797		$	(4,551	)	$	(4	)	$	2,392


Investing activities:
	Additions to property and equipment			(3,856	)		(4,850	)		--			--			(8,706	)

Net cash used in investing activities				(3,856	)		(4,850	)		--			--			(8,706	)


Financing activities:
	Proceeds from short-term debt			17,196			--			--			--			17,196
	Payments on long-term debt			(4,764	)		--			--			--			(4,764	)
	Proceeds from the exercise of stock options			3,015			--			--			--			3,015
	Proceeds from issuance of common stock for employee stock purchase plan			810			--			--			--			810
	Other			(71	)		--			--			--			(71	)
	Net change in intercompany obligations			(12,244	)		7,673			4,567			4			--

Net cash provided by financing activities				3,942			7,673			4,567			4			16,186

Effect of exchange rate changes on cash and cash equivalents				945			--			--			--			945
Net increase in cash and cash equivalents				1,181			9,620			16			--			10,817
Cash and cash equivalents at beginning of period				7,251			16,213			30			--			23,494

Cash and cash equivalents at end of period			$	8,432		$	25,833		$	46		$	--		$	34,311

- 22 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Statement of Cash Flows			Six Months Ended December 27, 2003

				Company			Non-Guarantors			11 3/4% Senior Subordinated Notes Guarantors			Eliminations			Total

Operating activities:
Net cash provided by (used in) operating activities				$	33,226		$	28,473		$	(172	)	$	(92	)	$	61,435


Investing activities:
		Additions to property and equipment			(3,731	)		(3,880	)		--			--			(7,611	)
	Proceeds from disposals of property and equipment				3			--			--			--			3
	Price adjustment to trademarks acquired in Arden acquisition				2,460			--			--			--			2,460

	Net cash used in investing activities				(1,268	)		(3,880	)		--			--			(5,148	)


Financing activities:
		Payments on short-term debt			(12,727	)		--			--			--			(12,727	)
		Payments on long-term debt			(104,086	)		--			--			--			(104,086	)
		Proceeds from the exercise of stock options			2,586			--			--			--			2,586
		Proceeds from the issuance of new common stock			62,668			--			--			--			62,668
		Repurchase of common stock			(398	)		--			--			--			(398	)
		Net change in intercompany obligations			19,803			(19,765	)		(130	)		92			--

Net cash used in financing activities					(32,154	)		(19,765	)		(130	)		92			(51,957	)

Effect of exchange rate changes on cash and cash equivalents					403			--			--			--			403
Net increase (decrease) in cash and cash equivalents					207			4,828			(302	)		--			4,733
Cash and cash equivalents at beginning of period					6,676			11,495			354			--			18,525

Cash and cash equivalents at end of period				$	6,883		$	16,323		$	52		$	--		$	23,258

NOTE 11. STATEMENT OF CASH FLOW - SUPPLEMENTAL INFORMATION

The Company incurred the following non-cash financing and investing activities:

(Amounts in thousands)	Six Months Ended

	December 31,		December 27,
	2004		2003

Accretion on Series D Convertible Preferred Stock (See Note 9)	$	--	$	1,698




Accelerated accretion on Series D Convertible Preferred Stock	$	--	$	18,584



Conversion to Common Stock	$	--	$	6,416
Accreted dividends not paid on Series D Convertible Preferred Stock		--		1,927

Conversion of Series D Convertible Preferred Stock	$	--	$	8,343

- 23 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 12. TRANSITIONAL PERIOD EVENTS

Due to the June 2004 change in the Company's fiscal year from January 31 to June 30, the Company filed a Transition Report for the transition period from February 1, 2004 to June 30, 2004 (the "Transition Period"). The following information includes footnote disclosure significant to the Transition Period and included in the Transition Report. This information is included to supplement the Company's financial information since its last audited consolidated financial statements and related footnotes included in the Company's Annual Report for the year ended January 31, 2004, and should be read in conjunction with the Transition Report and the Annual Report.

Senior Subordinated Notes and Other Long-Term Debt

On January 13, 2004, the Company completed the sale of $225.0 million aggregate principal amount of 7 3/4% Senior Subordinated Notes. The 7 3/4% Senior Subordinated Notes are guaranteed by the Company's wholly-owned U.S. subsidiaries DF Enterprises, Inc., FD Management, Inc., Elizabeth Arden International Holding, Inc., Elizabeth Arden (Financing), Inc., RDEN Management, Inc., and Elizabeth Arden Travel Retail, Inc. The net proceeds of approximately $219.4 million were used to redeem $95.2 million principal amount of its outstanding 11 3/4% Senior Notes and $104.3 million principal amount of its 10 3/8% Senior Notes due May 2007, of which $20.0 million principal amount was redeemed in January 2004 and $84.3 million principal amount was redeemed in February 2004.

On June 25, 2004, the Company closed the exchange offer of all of its outstanding $225.0 million aggregate principal amount 7 3/4% Senior Subordinated Notes sold in January 2004 for an equal aggregate principal amount of 7 3/4% Senior Subordinated Notes with substantially identical terms that are registered under the Securities Act of 1933, as amended.

In May 2004, the Company redeemed the $2.2 million in remaining principal amount of 8.5% Subordinated Debenture due 2004 plus accrued interest with borrowings from the Credit Facility. There was no gain or loss on this transaction.

Commitments and Contingencies

In November 2003, the Company announced that it would consolidate its U.S. distribution operations into a single distribution facility in Roanoke, Virginia by March 2004. The Roanoke facility was expanded in 2003 to approximately 400,000 square feet in order to accommodate the consolidated distribution activities. The Company ceased conducting distribution activities from the Miami Lakes facility at the end of January 2004 and is planning to sell the facility. The Company will continue to use the corporate offices located in the Miami Lakes facility until the facility is sold and then it will move its corporate offices to another location in the area. In connection with the consolidation, the U.S. workforce was reduced by approximately 10%. The consolidation was substantially completed in March 2004.

On June 30, 2004, the Company settled a breach of contract action filed in December 2000 by Adenat, Inc., a Canadian customer of Unilever. Adenat filed suit in the Ontario, Canada Superior Court of Justice against a number of Unilever affiliates, the Company and several individuals, including officers of Unilever and the Company who were subsequently removed from the case. Adenat alleged that Unilever breached contractual obligations owed to Adenat and that the Company interfered in that relationship. Adenat sought to enjoin the termination of the alleged distribution agreement by Unilever and sought compensatory damages of Canadian $55 million (approximately US $41 million at June 30, 2004) against each of Unilever and the Company, plus punitive damages of Canadian $35 million (approximately US $26 million at June 30, 2004). The Company did not pay or receive any amounts to settle the case.

- 24 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Public Offering of Common Stock

On June 15, 2004, the Company completed a public offering of 2,549,723 shares of its Common Stock, which were sold at $19.50 per share. Conopco, Inc. and Unilever United States Foundation, Inc., affiliates of Unilever, N.V. (the "Selling Shareholders"), sold 2,317,930 shares and the Company sold 231,793 shares pursuant to an over-allotment option granted by the Company and exercised by the underwriter in the offering. The shares sold by the Selling Shareholders represented the remaining shares of Common Stock underlying the Company's outstanding Series D Convertible Preferred Stock. The Company did not receive any proceeds from the sale of shares by the Selling Shareholders. The Company used the net proceeds it received from the exercise of the over-allotment option to reduce borrowings under the Credit Facility.

Stock Incentive Awards

On February 13, 2004, the Company authorized the grant of an aggregate of 40,578 shares of restricted stock to 189 employees that vest in full one year from the date of grant. These shares were recorded as unearned deferred compensation in shareholders' equity in the amount of approximately $734,000, which is being amortized over the one-year vesting period.

On March 10, 2004, the Company authorized the grant of stock options to 117 managerial employees for approximately 364,000 shares of Common Stock. The stock options are due to vest over three years in thirds each succeeding year from the date of grant, assuming the person receiving the grant is employed by the Company at the time of vesting. The exercise price of those stock options is $21.60 per share, which was the closing price of the Common Stock on the date of grant. The options expire ten years from the date of grant.

Also, on March 10, 2004, the Company authorized the grant of performance-based restricted stock to 107 managerial employees for approximately 192,000 shares of Common Stock. The performance-based restricted stock will vest as to one third of the stock granted on each of the Company's fiscal years ending June 30, 2005, 2006 and 2007, but only if the person receiving the grant is employed by the Company at the time of vesting and the Company achieves a cumulative annualized increase in earnings per share of 10%, excluding any one-time or extraordinary events (as determined by the compensation committee), and after giving effect to any stock splits or other recapitalizations. The restricted stock is being recorded as unearned deferred compensation in shareholders' equity in the amount of approximately $4.0 million and is being amortized over the three-year vesting period.

On April 21, 2004, the Company repurchased 20,226 shares of Common Stock at the $21.50 closing price as a result of the vesting of restricted stock of employees that elected to sell shares to the Company to cover personal income tax withholding obligations. The repurchase of these shares is permitted for those purposes under the Company's 2000 Stock Incentive Plan.

On June 22, 2004, the Company granted stock options for an aggregate of 35,000 shares of Common Stock to non-employee directors under the 2004 Non-Employee Director Plan which are exercisable three years from the date of grant if such persons continue to serve as directors on that date.

Related Party Transaction

In March 2002, the Company provided a loan to its current chairman and chief executive officer in the principal amount of $0.5 million (the "Note"), which matured on March 31, 2004 and bore interest at an annual rate of 5%. This loan replaced earlier loans made by the Company to its chairman and chief executive officer during the fiscal year ended January 31, 1999. In July 2002, the chairman and chief executive officer repaid to the Company $0.1 million of the principal amount of the Note. The remaining loan balance of $0.4 million plus accrued interest was repaid by the March 31, 2004 maturity date.

- 25 -

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Cautionary Note Regarding Forward-Looking Statements

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such Act) made in this quarterly report on Form 10-Q. Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans" and "projection") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. Accordingly, any such stateme nts are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations: our absence of contracts with customers or suppliers and our ability to maintain and develop relationships with customers and suppliers; international and domestic economic and business changes that could impact consumer confidence or operations; the impact of competitive products and pricing; risks of international operations, including foreign currency fluctuations, economic and political consequences of terrorist attacks, political instability in certain regions of the world, and diseases affecting customer purchasing patterns; our ability to successfully launch new products and implement our growth strategy; our ability to successfully and cost-effectively integrate acquired businesses or new brands; our substantial indebtedness, debt service obligations and restrictive covenants in our revolving credit facility and our indenture for our 7 3/4% se nior subordinated notes; our customers' financial condition; our ability to access capital for acquisitions; changes in product mix to less profitable products; the retention and availability of key personnel; the assumptions underlying our critical accounting estimates; delays in shipments, inventory shortages and higher costs of production due to interruption of operations at key third party manufacturing or fulfillment facilities that manufacture or provide logistic services for the majority of our supply of certain products; changes in the retail, fragrance and cosmetic industries; our ability to protect our intellectual property rights; changes in the legal, regulatory and political environment that impact, or will impact, our business, including changes to customs or trade regulations or accounting standards; and other risks and uncertainties. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

General

This discussion should be read in conjunction with the Notes to Unaudited Consolidated Financial Statements contained herein and Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in our Annual Report on Form 10-K for the year ended January 31, 2004 and our Transition Report on Form 10-Q for the five month period ended June 30, 2004. The results of operations for an interim period may not give a true indication of results for the year. In the following discussions, all comparisons are with the corresponding items in the prior year period.

Our operations have historically been seasonal, with higher sales generally occurring during the first half of the fiscal year (July through December) as a result of increased demand by retailers in anticipation of, and during, the holiday season. During the twelve months ended December 31, 2004, approximately 61% of our net sales were made during those months. Due to the size and timing of certain orders from our customers, sales, results of operations, working capital requirements and cash flows can vary between quarters of the same and different years. As a result, we expect to experience variability in net sales, net income, working capital requirements and cash flows on a quarterly basis.

- 26 -

We experience seasonality in our working capital, with peak inventory levels from July to October and peak receivable balances from September to January. Our working capital borrowings are also seasonal and are normally highest in the months of September, October and November. During the months of December, January and February of each year, significant cash is normally generated as customer payments on holiday season orders are received.

On June 2, 2004, our board of directors approved a change in fiscal year end from January 31 to June 30, effective as of June 30, 2004. The change was implemented to better reflect our business cycle and to enhance business planning relative to our customers' retail calendars. We filed a transition report on Form 10-Q for five month period ended June 30, 2004. The three and six month periods ended December 31, 2004 have one more day and two more days, respectively than the three and six month periods ended December 27, 2003.

Overview

For the three and six month periods ended December 31, 2004, net sales increased 9.0% and 8.1%, respectively, compared to the three and six month periods ended December 27, 2003 as a result of the launch of the Curious Britney Spears fragrance in the U.S. in September 2004 and in select international markets in October 2004, the launch of Elizabeth Arden Provocative Woman fragrance in the U.S. in Spring 2004 and internationally in Summer 2004 and the favorable impact of foreign currency rates and increased sales in certain international markets, partially offset by lower sales to certain U.S. retail customers. Gross margin increased to 43.8% from 41.5% for the three month period ended December 31, 2004 compared to the three month period ended December 27, 2003 and 43.2% from 40.6% for the six month period ended December 31, 2004 compared to the six month period ended December 27, 2003, reflecting a greater proportion of sales of hig her margin owned and licensed brands than distributed brands, favorable impact of foreign currency rates and operational savings. For the three and six month periods ended December 31, 2004, selling, general and administrative expenses increased 21.6% and 19.3%, respectively, compared to the three and six month periods ended December 27, 2003 as a result of additional advertising to support new product launches, including the use of television and print advertising for the Curious Britney Spears and Elizabeth Arden Provocative Woman fragrances and the adverse impact of foreign currency rates. During the three and six month periods ended December 31, 2004, interest expense decreased by $3.1 million and $7.6 million, respectively, as a result of our debt refinancing activities during 2004. The increase in advertising and promotional activities was funded with a portion of the interest expense and operational savings. We anticipate continuing to use savings in interest expense to fund br and development and working capital requirements during the fiscal year ending June 30, 2005.

Critical Accounting Policies and Estimates

We believe the accounting policies below represent our critical accounting policies. See our Annual Report on Form 10-K for the year ended January 31, 2004 for a detailed discussion on the application of these and other accounting policies.

Accounting for Acquisitions and Intangible Assets. We have accounted for our acquisitions, including the acquisition of the Elizabeth Arden business, under the purchase method of accounting for business combinations. Under the purchase method of accounting, the cost, including transaction costs, are allocated to the underlying net assets, based on their respective estimated fair values. The excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.

The judgments made in determining the estimated fair value and expected useful lives assigned to each class of assets and liabilities acquired can significantly affect net income. For example, different classes of assets will have useful lives that differ - the useful life of property, plant, and equipment acquired will differ substantially from the useful life of brand licenses and trademarks. Consequently, to the extent a longer-lived asset is ascribed greater value under the purchase method than a shorter-lived asset, net income in a given period may be higher.

Determining the fair value of certain assets and liabilities acquired is judgmental in nature and often involves the use of significant estimates and assumptions. One of the areas that require more judgment is determining the fair values and useful lives of intangible assets. To assist in this process, we often obtain appraisals from independent valuation firms for certain intangible assets.

- 27 -

Our intangible assets generally consist of exclusive brand licenses and trademarks. We do not carry any goodwill. The value of our intangible assets, including brand licenses, trademarks and intangibles, is exposed to future adverse changes if we experience declines in operating results or experience significant negative industry or economic trends. We periodically review intangible assets, at least annually or more often as circumstances dictate, for impairment and the useful life assigned using the guidance of applicable accounting literature.

We have determined that the Elizabeth Arden trademarks have indefinite useful lives as cash flows from the use of the trademarks are expected to be generated indefinitely. In April 2004, we completed our annual impairment testing of these assets with the assistance of a third party valuation firm. The analysis and assessments of these assets indicated that no impairment adjustment was required.

Long-Lived Assets. We review for impairment long-lived assets to be held and used whenever events or changes in circumstances indicate that the carrying amount of such assets may not be fully recoverable. Measurement of an impairment loss is based on the fair value of the asset compared to its carrying value. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. During the three and six months ended December 31, 2004 and December 27, 2003, we did not recognize any impairment charges associated with our long-lived assets.

Revenue Recognition. Sales are recognized when title and risk of loss transfers to the customer and collectibility of the resulting receivable is probable. Sales are recorded net of estimated returns and other allowances. The provision for sales returns represents management's estimate of future returns based on historical experience and considering current external factors and market conditions.

Allowances for Sales Returns and Markdowns. As is customary in the prestige beauty business, we grant certain of our customers, subject to our authorization and approval, the right to either return product or to receive a markdown allowance for certain promotional product. Upon sale, we record a provision for product returns and markdowns estimated based on our historical and projected experience, economic trends and changes in customer demand. There is considerable judgment used in evaluating the factors influencing the allowance for returns and markdowns, and additional allowances in any particular period may be needed.

Allowances for Doubtful Accounts Receivable. We maintain allowances for doubtful accounts to cover uncollectible accounts receivable, and we evaluate our accounts receivable to determine if they will ultimately be collected. This evaluation includes significant judgments and estimates, including an analysis of receivables aging and a customer-by-customer review for large accounts. If, for example, the financial condition of our customers deteriorates resulting in an impairment of their ability to pay, additional allowances may be required.

Provisions for Inventory Obsolescence. We record a provision for estimated obsolescence and shrinkage of inventory. Our estimates consider the cost of inventory, forecasted demand, the estimated market value, the shelf life of the inventory and our historical experience. If there are changes to these estimates, additional provisions for inventory obsolescence may be necessary.

Stock-Based Compensation. We account for our stock-based compensation under the recognition and measurement principles prescribed by Accounting Principles Board Opinion ("APB") No. 25, "Accounting for Stock Issued to Employees," and related interpretations. No stock-based compensation cost is reflected in net income for employee and director option grants, as such grants had an exercise price equal to the market value of the underlying common stock on the date of grant. The pro forma effect on net income and net income per common share for the three and six month periods ended December 31, 2004 and December 27, 2003 is set forth in Note 3 to the Notes to Unaudited Consolidated Financial Statements.

In December 2004, the Financial Accounting Standards Board ("FASB") issued its final standard on accounting for share-based payments (SBP), FASB Statement No.123R (revised 2004), Share-Based Payment (FAS 123R) that requires companies to expense the value of employee stock options and similar awards. Under SFAS 123R, SBP awards result in a cost that will be measured at fair value on the awards grant date, based on the estimated number of awards that are expected to vest. Compensation cost for awards that vest would not be reversed if the awards expire without being exercised. Therefore, SFAS 123R will be effective for the Company's three month period ending September 30, 2005. We are evaluating the impact that SFAS 123R will have on compensation expense for future periods.

- 28 -

Performance Accelerated Restricted Stock (PARS). PARS are restricted stock awards with a pre-defined vesting period of six years that also provide for accelerated vesting to three, four or five years from the date of grant if our total shareholder return exceeds the total shareholder return of the median of the companies comprising the Russell 2000 Index over the respective three, four or five-year period. A new grant of PARS is expected to occur when the initial grant vests. The PARS are recorded as unearned deferred compensation in shareholders' equity at the market value on the date of grant and will be amortized over a six-year vesting period for the first two years following the date of grant but may be accelerated after two years based on our probability of exceeding the total shareholder return of the median of the companies comprising the Russell 2000 Index. As a result of our total shareholder return exceeding the median of t he companies comprising the Russell 2000 Index over the past two-year period from the date the PARS were granted, we are accelerating the amortization based on the likelihood that accelerated vesting will occur on the third anniversary of the date of the grant. We anticipate incurring approximately $0.8 million of remaining amortization expense during the three months ended March 31, 2005 in connection with the vesting of the March 2002 PARS grant.

Performance-Based Restricted Stock. The performance-based restricted stock granted in March 2004 will vest as to one third of the stock granted on each of the first, second and third full annual fiscal years following the date of grant, but only if the person receiving the grant is employed by us at the time of vesting and we achieve a cumulative annualized increase in earnings per share of 10%, excluding any one-time or extraordinary events (as determined by the compensation committee of the board of directors), and after giving effect to any stock splits or other recapitalizations. The restricted stock is recorded as unearned deferred compensation in shareholders' equity, is marked to market during each quarterly reporting period and is amortized over the three-year vesting period.

Income Taxes and Valuation Reserves. A valuation allowance may be required to reduce deferred tax assets to the amount that is more likely than not to be realized. We consider projected future taxable income and ongoing tax planning strategies in assessing a potential valuation allowance. In the event we determine that we may not be able to realize all or part of our deferred tax asset in the future, or that new estimates indicate that a previously recorded valuation allowance is no longer required, an adjustment to the deferred tax asset would be charged or credited to net income in the period of such determination.

[Remainder of Page Intentionally Left Blank]

- 29 -

Results of Operations

The following discussion compares the historical results of operations for the three and six month periods ended December 31, 2004 and December 27, 2003. Results of operations, in thousands and as a percentage of net sales, were as follows (percentages may not add due to rounding):

		Three Months Ended								Six Months Ended

		December 31, 2004				December 27, 2003				December 31, 2004				December 27, 2003

Net sales		$	322,951	100.0	%	$	296,256	100.0	%	$	535,107	100.0	%	$	495,241	100.0	%
Cost of sales			181,348	56.2			173,309	58.5			303,993	56.8			294,045	59.4
	Gross profit		141,603	43.8			122,947	41.5			231,114	43.2			201,196	40.6
Selling, general and administrative expenses			83,944	26.0			69,010	23.3			154,902	28.9			129,830	26.2
Depreciation and amortization			5,449	1.7			5,373	1.8			10,982	2.1			10,485	2.1
	Income from operations		52,210	16.2			48,564	16.4			65,230	12.2			60,881	12.3
Interest expense, net			6,274	1.9			9,377	3.2			12,259	2.3			19,851	4.0
Debt extinguishment charges			--	--			9,446	3.2			--	--			9,446	1.9
	Income before income taxes		45,936	14.2			29,741	10.0			52,971	9.9			31,584	6.4
Provision for income taxes			14,210	4.4			8,536	2.9			16,462	3.1			9,064	1.8
	Net income		31,726	9.8			21,205	7.2			36,509	6.8			22,520	4.6
Accretion and dividend on preferred stock			--	--			695	0.2			--	--			1,698	0.3
Accelerated accretion on converted preferred stock			--	--			18,584	6.3			--	--			18,584	3.8
Net income attributable to common shareholders		$	31,726	9.8	%	$	1,926	0.7	%	$	36,509	6.8	%	$	2,238	0.5	%
Other data
EBITDA and EBITDA margin (1)		$	57,659	17.9	%	$	44,491	15.0	%	$	76,212	14.2	%	$	61,920	12.5	%

(1) For a definition of EBITDA and a reconciliation of net income to EBITDA, see "EBITDA" under Results of Operations - Three Months Ended December 31, 2004 Compared to Three Months Ended December 27, 2003. EBITDA margin represents EBITDA divided by net sales.

Three Months Ended December 31, 2004 Compared to Three Months Ended December 27, 2003

Net Sales. Net sales increased approximately 9.0% for the three months ended December 31, 2004 over the three months ended December 27, 2003. The sales increase was driven primarily by the launch of the Curious Britney Spears fragrance in the U.S. in September 2004 and in select international markets in October 2004, the launch of Elizabeth Arden Provocative Woman fragrance in the U.S. in Spring 2004 and internationally in Summer 2004 and the favorable impact of foreign currency rates and increased sales in certain international markets, partially offset by lower sales to certain U.S. retail customers. Excluding the impact of foreign currency translation, net sales increased 6.8%.

Gross Profit. Gross profit increased 15.2% for the three months ended December 31, 2004 over the three months ended December 27, 2003. The increase in gross profit was due to higher net sales, including a greater proportion of sales of higher margin owned and licensed brands than distributed brands, the favorable impact of foreign currency rates and operational savings. Gross margin increased to 43.8% for the three months ended December 31, 2004, from 41.5% for the three months ended December 27, 2003.

SG&A. Selling, general and administrative expenses increased 21.6% for the three months ended December 31, 2004 over the three months ended December 27, 2003. The increase was principally due to additional advertising to support new product launches, including the use of television and print advertising for the Curious Britney Spears and Elizabeth Arden Provocative Woman fragrances and the adverse impact of foreign currency rates.

- 30 -

Interest Expense. Interest expense, net of interest income, decreased by 33.1% for the three months ended December 31, 2004, compared to the three months ended December 27, 2003. The decrease resulted from lower interest expense on our long-term debt due to refinancing activities in fiscal 2004.

Debt Extinguishment Charges. We did not incur any debt extinguishment charges in the three months ended December 31, 2004 compared to the $9.4 million of debt extinguishment charges relating to the redemption of $56 million aggregate principal amount of the 11 3/4% senior notes and $40 million aggregate principal amount of the 10 3/8% senior notes recorded for the three months ended December 27, 2003. See Note 7 to the Notes to Unaudited Consolidated Financial Statements.

Provision for Income Taxes. The effective income tax rate for the three months ended December 31, 2004 of 30.9% has increased from 28.7% for the three months ended December 27, 2003 due to the expected increase in U.S. taxable income relative to consolidated income for the full fiscal year.

Net Income. Net income for the three months ended December 31, 2004 increased by approximately $10.5 million as compared to the three months ended December 27, 2003. The increase was a result of the debt extinguishment charges in the prior year, lower interest expense and higher operating income, partially offset by a higher tax rate.

Accretion and Dividend on Preferred Stock. As a result of the conversion of the remaining Series D convertible preferred stock into common stock in June 2004, there are no future accretion and dividend charges relating to preferred stock. For the three months ended December 27, 2003, the accretion and dividend on preferred stock of $0.7 million, which is a non-cash charge to net income attributable to common shareholders, represents the accretion of the original carrying value of $8.5 million of the Series D convertible preferred stock to its liquidation preference, and the imputed dividends on such preferred stock.

Accelerated Accretion on Converted Preferred Stock. As a result of the conversion of the remaining Series D convertible preferred stock into common stock in June 2004, there was no accelerated accretion charges relating to the preferred stock in the three months ended December 31, 2004. During the three months ended December 27, 2003, we recorded $18.6 million in accelerated accretion charges as a result of the conversion of Series D convertible preferred stock into common stock and sold by an affiliate of Unilever in a public offering in October 2003.

Net Income Attributable to Common Shareholders. In the three months ended December 31, 2004, the net income attributable to common shareholders increased by $29.8 million compared to the three months ended September 28, 2003, due to an increase in net income, and the accelerated accretion and elimination of accretion and dividends on the Series D convertible preferred stock.

EBITDA. EBITDA (net income plus the provision for income taxes (or net loss less the benefit from income taxes), plus interest expense, plus depreciation and amortization expense) increased by 29.6% for the three months ended December 31, 2004, as compared to the three months ended December 27, 2003. The increase in EBITDA was primarily the result of the debt extinguishment charges in the prior year period and the increased net sales and gross profit during the three months ended December 31, 2004, partially offset by higher selling, general and administrative expenses.

EBITDA should not be considered as an alternative to operating income (loss) or net income (loss) (as determined in accordance with generally accepted accounting principles) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with generally accepted accounting principles) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure (particularly when acquisitions are involved), depreciation and amortization, which can vary significantly depending upon accounting methods (particularly when acquisitions are involved) or non-operating factors such as historical cost. Accordingly, as a resul t of our capital structure and the accounting method used for our acquisitions, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures.

- 31 -

In addition, EBITDA has limitations as an analytical tool, including the fact that:

—		it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

—		it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;

—		it does not reflect any cash income taxes that we may be required to pay; and

—		although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and these measures do not reflect any cash requirements for such replacements.

The following is a reconciliation of net income, as determined in accordance with generally accepted accounting principles, to EBITDA:

(Amounts in thousands)			Three Months Ended

			December 31, 2004		December 27, 2003

Net income			$	31,726	$	21,205
Plus:
	Provision for income taxes			14,210		8,536
	Interest expense, net			6,274		9,377
	Depreciation and amortization			5,449		5,373

		EBITDA	$	57,659	$	44,491

Six Months Ended December 31, 2004 Compared to the Six Months Ended December 27, 2003

Net Sales. Net sales increased approximately 8.0% for the six months ended December 31, 2004 over the six months ended December 27, 2003. The sales increase was driven primarily by the launch of the Curious Britney Spears fragrance in the U.S. in September 2004 and in select international markets in October 2004, the launch of Elizabeth Arden Provocative Woman fragrance in the U.S. in Spring 2004 and internationally in Summer 2004 and the favorable impact of foreign currency rates and increased sales in certain international markets, partially offset by lower sales to certain U.S. retail customers. Excluding the impact of foreign currency translation, net sales increased 5.7%

Gross Profit. Gross profit increased 14.9% for the six months ended December 31, 2004 over the six months ended December 27, 2003. The increase in gross profit was due to higher net sales, including a greater proportion of sales of higher margin owned and licensed brands than distributed brands and the favorable impact of foreign currency rates. Gross margin increased to 43.2% for the six months ended December 31, 2004, from 40.6% for the six months ended December 27, 2003.

SG&A. Selling, general and administrative expenses increased 19.3% for the six months ended December 31, 2004 over the six months ended December 27, 2003. The increase was principally due to additional advertising to support new product launches, including the use of television and print advertising for the Curious Britney Spears and Elizabeth Arden Provocative Woman fragrances and the adverse impact of foreign currency rates.

Depreciation and Amortization. Depreciation and amortization increased 4.7% for the six months ended December 31, 2004, compared to the six months ended December 27, 2003, principally as a result of the acceleration of depreciation of certain fixed assets at our Miami Lakes facility due to the cessation of distribution operations at this facility and the accelerated amortization of a license agreement relating to products we plan to discontinue.

- 32 -

Interest Expense. Interest expense, net of interest income, decreased by 38.2% for the six months ended December 31, 2004 in comparison to the six months ended December 27, 2003. The decrease resulted from lower interest expense on our long-term debt due to refinancing activities.

Debt Extinguishment Charges. We did not incur any debt extinguishment charges in the six months ended December 31, 2004 compared to the $9.4 million of debt extinguishment charges relating to the redemption of $56 million aggregate principal amount of the 11 3/4% senior notes and $40 million aggregate principal amount of the 10 3/8% senior notes recorded for the three months ended December 27, 2003. See Note 7 to the Notes to Unaudited Consolidated Financial Statements.

Provision for Income Taxes. The effective income tax rate for the three months ended December 31, 2004 of 31.0% has increased from 28.7% for the three months ended December 27, 2003 due to the expected increase in U.S. taxable income relative to consolidated income for the full fiscal year.

Net Income. Net income for the six months ended December 31, 2004 increased by approximately $14.0 million as compared to the six months ended December 27, 2003. The increase was a result of the debt extinguishment charges in the prior year, lower interest expense and higher operating income, partially offset by a higher tax rate.

Accretion and Dividend on Preferred Stock. As a result of the conversion of the remaining Series D convertible preferred stock into common stock in June 2004, there are no future accretion and dividend charges relating to preferred stock. For the six months ended December 27, 2003, the accretion and dividend on preferred stock of $1.7 million, which is a non-cash charge to net income attributable to common shareholders, represents the accretion of the original carrying value of the Series D convertible preferred stock to its liquidation preference, and the imputed dividends on such preferred stock.

Accelerated Accretion on Converted Preferred Stock. As a result of the conversion of the remaining Series D convertible preferred stock into common stock in June 2004, there was no accelerated accretion charges relating to the preferred stock in the six months ended December 31, 2004. During the six months ended December 27, 2003, we recorded $18.6 million in accelerated accretion charges as a result of the conversion of Series D convertible preferred stock into common stock and sold by an affiliate of Unilever in a public offering in October 2003.

Net Income Attributable to Common Shareholders. During the six months ended December 31, 2004, the net income attributable to common shareholders increased by $34.3 million compared to the six months ended December 27, 2003, due to an increase in net income and the elimination of accretion and dividends on the Series D convertible preferred stock, including accelerated accretion during the six months ended December 27, 2003.

EBITDA. EBITDA (net income plus the provision for income taxes (or net loss less the benefit from income taxes), plus interest expense, plus depreciation and amortization expense) increased by 23.1% for the six months ended December 31, 2004, as compared to the six months ended December 27, 2003. The increase in EBITDA was primarily the result of the debt extinguishment charges in the prior year period, the increased net sales and gross profit during the six months ended December 31, 2004, partially offset by higher selling, general and administrative expenses.

The following is a reconciliation of net income, as determined in accordance with generally accepted accounting principles, to EBITDA:

(Amounts in thousands)			Six Months Ended

			December 31, 2004		December 27, 2003

Net income			$	36,509	$	22,520
Plus:
	Provision for income taxes			16,462		9,064
	Interest expense, net			12,259		19,851
	Depreciation and amortization			10,982		10,485

		EBITDA	$	76,212	$	61,920

- 33 -

Financial Condition

(Amounts in thousands)	Six Months Ended

	December 31, 2004			December 27, 2003

Net cash provided by operating activities	$	2,392		$	61,435
Net cash used in investing activities		(8,706	)		(5,148	)
Net cash provided by (used in) financing activities		16,186			(51,957	)
Net increase in cash and cash equivalents		10,817			4,733

Cash Flows. Net cash provided by operating activities decreased 96.1% for the six months ended December 31, 2004 as compared to the six months ended December 27, 2003. The decrease for the six months ended December 31, 2004 was primarily due to an increase in accounts receivable related to the timing of sales and an increase in inventories to support new product launches, partially offset by an increase in accounts payable due to the timing of payments to vendors. Approximately two thirds of our net sales for the three months ended December 31, 2004 occurred during the last two months of the quarter compared to approximately one third in the prior year due to retailers purchasing later in the selling season to better manage their inventory levels.

Net cash used in investing activities increased by 69.1% for the six months ended December 31, 2004 as compared to the six months ended December 31, 2003 primarily as a result of the final price adjustment to trademarks acquired in the Arden acquisition in the prior year.

Net cash provided by financing activities increased by $68.1 million for the six months ended December 31, 2004 as compared to the six months ended December 27, 2003. The increase in net cash provided by financing activities for the six months ended December 31, 2004 was primarily due to increased short-term borrowings used to finance increases in accounts receivable, inventory and selling, general and administrative expenses and significantly higher payments on short and long-term debt during the six months ended December 27, 2003.

Interest paid during the six months ended December 31, 2004 included a $9.6 million interest payment on the 7 3/4% senior subordinated notes that covered the period from the January 13, 2004 date of issuance through August 15, 2004.

Future Liquidity and Capital Needs. Our principal future uses of funds are for working capital requirements, including brand development and marketing expenses, new product launches, additional brand acquisitions or product distribution arrangements, capital expenditures and debt service. We have historically financed, and we expect to continue to finance, our needs primarily through internally generated funds, our credit facility and external financing. We collect cash from our customers based on our sales to them and their respective payment terms.

We have a revolving bank credit facility with a syndicate of banks that matures in June 2009. Our borrowings under this facility are limited to a "borrowing base," calculated based on 85% of eligible accounts receivable and 75% of eligible inventories (65% from November 16 to May 15). The borrowings are collateralized by a first priority lien on all of our U.S. accounts receivable and inventory. The credit facility prohibits the payment of cash dividends and the incurrence of debt (other than refinancing and certain small amounts of indebtedness). The credit facility has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if average borrowing availability declines to less than $25 million ($40 million from November 16 through May 15). No financial maintenance covenant was applicable for the three and six month periods ended December 31, 2004. In addition, the indenture pursua nt to which our 73/4% senior subordinated notes are issued restricts the incurrence of debt (other than refinancing indebtedness and certain other indebtedness) and the payment of dividends subject to satisfaction of a fixed charge coverage ratio and net income tests.

On September 30, 2004, we executed an amendment to our credit facility that, among other things, extended the maturity date to June 2009 from January 2006 and included a reduction in the range of interest rates included in the applicable margin, added to either LIBOR-based rates or prime rates, at our option for outstanding borrowings. As a result of the September 2004 amendment to the credit facility, the interest rates charged on LIBOR loans and prime rate loans were reduced to a range of 1.50% to 2.25% from a range of 2.00% to 2.75% for LIBOR loans and to a range of 0% to .50% from a range of 0.25% to 1.00% for prime rate borrowings. As of December 31, 2004, the applicable margin was

- 34 -

1.75% for LIBOR loans and 0% for prime rate loans. The commitment fee on the unused portion of the credit facility ranges from 0.25% to 0.375% per year based on a debt service coverage ratio. At December 31, 2004, the commitment fee was 0.30%. See Note 6 to Notes to Unaudited Consolidated Financial Statements.

Based upon our internal projections, we believe that the credit facility, as currently amended and restated, provides sufficient flexibility so that we will remain in compliance with its terms. If our actual results deviate significantly from our projections, however, we may not remain in compliance with the debt service coverage ratio and would not be allowed to borrow under the revolving credit facility. In addition, a default under our revolving credit facility that causes acceleration of the debt under this facility could trigger a default on our senior notes. In the event we are not able to borrow under our credit facility, we would be required to develop an alternative source of liquidity. There is no assurance that we could obtain replacement financing or what the terms of such financing, if available, would be. As of December 31, 2004, we had $83 million in outstanding borrowings under our credit facility and approximately $167 million of eligibl e receivables and inventories available as collateral under the credit facility. Therefore, we had $84 million borrowing availability under the credit facility.

We believe that existing cash and cash equivalents, internally generated funds and borrowings under our credit facility will be sufficient to cover debt service, working capital requirements and capital expenditures for the next twelve months other than additional working capital requirements that may result from further expansion of our operations through acquisitions of additional brands or new product launches or distribution arrangements.

Contractual Obligations. At December 31, 2004, we had commitments to incur promotional and advertising expenses, which are either fixed commitments or based on net sales for licensed brands, and minimum royalty guarantees in an aggregate amount of $10.3 million through 2009 compared with $33.5 million as previously stated in our Transition Report at June 30, 2004.

Recently Issued Accounting Pronouncements and Recent Legislation

In December 2004, the FASB issued its final standard on accounting for share-based payments (SBP), FASB Statement No.123R (revised 2004), Share-Based Payment (SFAS 123R) that requires companies to expense the value of employee stock options and similar awards. Under SFAS 123R, SBP awards result in a cost that will be measured at fair value on the awards' grant date, based on the estimated number of awards that are expected to vest. Compensation cost for awards that vest would not be reversed if the awards expire without being exercised. The effective date for public companies is interim and annual periods beginning after June 15, 2005, and applies to all outstanding and unvested SBP awards at a company's adoption date. Therefore, SFAS 123R will affect us beginning in the three month period ending September 30, 2005. We are evaluating the impact that SFAS 123R will have on compensation expense for future periods.

In October 2004, the American Jobs Creation Act of 2004 was signed into law. This act contains a number of provisions that might affect our future effective tax rate. The most significant provision would allow us to elect to deduct from our taxable income 85% of certain eligible dividends received by us from non-U.S. subsidiaries before the end of 2005 if those dividends are reinvested in the U.S. for eligible purposes. Another significant provision replaces the extraterritorial income exclusion with a domestic manufacturing deduction. To the extent we remit eligible dividends, we would have to record a provision for U.S. federal and state income taxes on the taxable portion of the remittance as no taxes have been previously provided. We are evaluating the impact this act will have on our effective tax rate for this fiscal year and beyond.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk

As of December 31, 2004, we had $83.1 million in borrowings outstanding under our credit facility. Borrowings under our credit facility are seasonal, with peak borrowings in the months of September, October and November. Borrowings under the credit facility are subject to variable rates and, accordingly, our earnings and cash flow will be affected by changes in interest rates. In February 2004, we entered into two interest rate swap transactions to swap $50.0 million of our fixed rate 7 3/4% senior subordinated notes due 2014 to a floating rate of interest based on LIBOR to

- 35 -

better balance our mix of fixed and floating rate debt. In the short term, this will provide us with a lower level of interest expense related to a portion of the 7 3/4% senior subordinated notes based on current LIBOR rates; however, over the life of the notes, interest expense may be greater than 7 3/4% based upon fluctuations in LIBOR. In the event of an adverse change in interest rates, our results could be negatively affected. We can terminate the swap at our option at any time and the counter party can call the swap any time after January 2009. We designated the swap as a fair value hedge.

Foreign Currency Risk

We sell our products in approximately 90 countries around the world. During the three and six month periods ended December 31, 2004, we derived approximately 33% and 34%, respectively, of our net sales from our international operations. During the three and six month periods ended December 27, 2003, we derived approximately 31% of our net sales from our international operations. We conduct our international operations in a variety of different countries and derive our sales in currencies including the Euro, British pound, Swiss franc, Canadian dollar and Australian dollar, as well as the U.S. dollar. Our operations may be subject to volatility because of currency changes, inflation changes and changes in political and economic conditions in the countries in which we operate. With respect to international operations, our sales and expenses are typically denominated in local currency, while costs of goods sold are denominated in a combination of local cu rrency and the U.S. dollar. Our results of operations are reported in U.S. dollars. Fluctuations in currency rates can affect our reported sales, margins, operating costs and the anticipated settlement of our foreign denominated receivables and payables. Most of our skincare and cosmetic products are produced in a third-party manufacturing facility located in Roanoke, Virginia. A weakening of the foreign currencies in which we generate sales relative to the currencies in which our costs are denominated, which is primarily the U.S. dollar, may decrease our reported cash flow and operating profits. Our competitors may or may not be subject to the same fluctuations in currency rates, and our competitive position could be affected by these changes. The cumulative effect of translating balance sheet accounts from the functional currency into the U.S. dollar at current exchange rates is included in "Accumulated other comprehensive income" on our consolidated balance sheets.

As of December 31, 2004, we had notional amounts of 40.6 million Euros and 10.4 million British pounds under foreign currency contracts that expire between January 31, 2005 and June 30, 2007 to reduce the exposure of our foreign subsidiary revenues to fluctuations in currency rates. We have designated each foreign currency option contract as a cash flow hedge. The unrealized loss, net of taxes, at December 31, 2004 associated with these contracts of approximately $3.3 million is included in accumulated other comprehensive income. The unrealized loss, net of taxes, incurred during the six months ended December 31, 2004 was approximately $3.4 million. We intend to only enter into foreign currency contracts that qualify for hedge accounting and, therefore, the gains and losses will only be recognized in earnings in the period in which the contracts expire. We do not utilize foreign exchange contracts for trading or speculative purposes. There can be no assurance that our hedging operations, if any, will eliminate or substantially reduce risks associated with fluctuating exchange rates.

ITEM 4. CONTROLS AND PROCEDURES

The Company's Chairman and Chief Executive Officer and Executive Vice President and Chief Financial Officer, who are the principal executive officer and principal financial officer, respectively, have evaluated the effectiveness and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this quarterly report (the "Evaluation Date"). Based upon such evaluation, they have concluded that, as of the Evaluation Date, the Company's disclosure controls and procedures are functioning effectively to provide reasonable assurance that information required to be disclosed by the Company in its reports filed or submitted by it under the Securities Exchange Act of 1934, as amended, has been recorded, processed, summarized and reported within the time periods specified in the Commission's rules and forms.

There have been no changes in the Company's internal control over financial reporting during the fiscal quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

- 36 -

PART II. OTHER INFORMATION

ITEM 6. EXHIBITS

Exhibit Number		Description

3.1		Amended and Restated Articles of Incorporation of the Company dated January 24, 2001 (incorporated herein by reference to Exhibit 3.1 filed as part of the Company's Form 8-K dated February 7, 2001 (Commission File No. 1-6370)).

3.2		Amended and Restated By-laws of the Company (incorporated herein by reference to Exhibit 3.2 filed as part of the Company's 10-Q for the transition period from February 1, 2004 to June 30, 2004 (Commission File No. 1-6370)).

4.1		Indenture, dated as of January 23, 2001, among the Company, FD Management, Inc., DF Enterprises, Inc., FFI International, Inc., Elizabeth Arden GmbH, as guarantors, and HSBC Bank USA, as trustee (incorporated herein by reference to Exhibit 4.1 filed as part of the Company's Form 8-K dated February 7, 2001 (Commission File No. 1-6370)).

4.2		Supplemental Indenture, dated as of January 8, 2004, among the Company and FD Management, Inc., DF Enterprises, Inc., Elizabeth Arden International Holding, Inc., and Elizabeth Arden (Zug) GmbH, as guarantors and HSBC Bank USA, as trustee (incorporated herein by reference to Exhibit 4.2 filed as part of the Company's Form 10-K for the year ended January 31, 2004 (Commission File No. 1-6370)).

4.3		Indenture, dated as of January 13, 2004, among the Company and FD Management, Inc., DF Enterprises, Inc., Elizabeth Arden International Holding, Inc., RDEN Management, Inc., Elizabeth Arden (Financing), Inc., and Elizabeth Arden Travel Retail, Inc., as guarantors, and HSBC Bank USA, as trustee (incorporated herein by reference to Exhibit 4.3 to the Company's Form 10-K for the year ended January 31, 2004 (Commission File No. 1-6370)).

4.4		Second Amended and Restated Credit Agreement dated as of December 24, 2002 among the Company, JP Morgan Chase Bank, as administrative agent, Fleet National Bank, as collateral agent, and the banks listed on the signature pages thereto (incorporated by reference to Exhibit 4.1 filed as part of the Company's Form 8-K dated December 30, 2002 (Commission File No. 1-6370)).

4.5		First Amendment to Second Amended and Restated Credit Agreement dated as of February 25, 2004, among the Company, JP Morgan Chase Bank, as administrative agent, Fleet National Bank, as collateral agent, and the banks listed on the signature pages thereto (incorporated herein by reference to Exhibit 4.5 to the Company's Form 10-K for the year ended January 31, 2004 (Commission File No. 1-6370)).

4.6		Second Amendment to Second Amended and Restated Credit Agreement dated as of June 2, 2004, among the Company, JP Morgan Chase Bank, as administrative agent, Fleet National Bank, as collateral agent, and the banks listed on the signature pages thereto (incorporated herein by reference to Exhibit 4.6 to the Company's Form 10-Q for the quarter ended May 1, 2004 (Commission File No. 1-6370)).

4.7		Third Amendment to Second Amended and Restated Credit Agreement dated as of September 30, 2004, among the Company, JP Morgan Chase Bank, as administrative agent, Fleet National Bank, as collateral agent, and the banks listed on the signature pages thereto (incorporated herein by reference to Exhibit 4.1 filed as part of the Company's Form 8-K dated October 1, 2004 (Commission File No. 1-6370)).

4.8		Amended and Restated Security Agreement dated as of January 29, 2001, made by the Company and certain of its subsidiaries in favor of Fleet National Bank, as administrative agent (incorporated herein by reference to Exhibit 4.5 filed as part of the Company's Form 8-K dated February 7, 2001 (Commission File No. 1-6370)).

10.1		2004 Stock Incentive Plan (incorporated herein by reference to Annex E filed as part of the Company's Proxy Statement on May 14, 2004 (Commission File No. 1-6370)).

10.2		2004 Non-Employee Director Stock Option Plan (incorporated herein by reference to Annex F filed as part of the Company's Proxy Statement on May 14, 2004 (Commission File No. 1-6370)).

- 37 -

Exhibit Number		Description

10.3		Amended 2000 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.1 filed as part of the Company's Form 10-Q for the quarter ended July 26, 2003 (Commission File No. 1-6370)).

10.4		Amended 1995 Stock Option Plan (incorporated herein by reference to Exhibit 4.12 filed as a part of the Company's Registration Statement on Form S-8 dated July 7, 1999 (Commission File No. 1-6370)).

10.5		Amended 2002 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 10.4 filed as a part of the Company's Form 10-Q for the quarter ended April 26, 2003 (Commission File No. 1-6370)).

10.6		Amended and Restated Deed of Lease dated as of January 17, 2003, between the Company and Liberty Property Limited Partnership (incorporated herein by referenced to Exhibit 10.5 filed as a part of the Company's Form 10-Q for the quarter ended April 26, 2003 (Commission File No. 1-6370)).

31.1		Section 302 Certification of Chief Executive Officer.

31.2		Section 302 Certification of Chief Financial Officer.

32		Section 906 Certifications of the Chief Executive Officer and the Chief Financial Officer.

The foregoing list omits instruments defining the rights of holders of our long-term debt where the total amount of securities authorized thereunder does not exceed 10% of our total assets. We hereby agree to furnish a copy of each such instrument or agreement to the Commission upon request.

- 38 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		ELIZABETH ARDEN, INC.

Date: February 7, 2005		/s/ E. Scott Beattie

		E. Scott Beattie
		Chairman and Chief Executive Officer
		(Principal Executive Officer)

Date: February 7, 2005		/s/ Stephen J. Smith

		Stephen J. Smith
		Executive Vice President and Chief Financial Officer
		(Principal Financial and Accounting Officer)

- 39 -

EXHIBIT INDEX

Exhibit Number		Description

31.1		Section 302 Certification of Chief Executive Officer.

31.2		Section 302 Certification of Chief Financial Officer.

32		Section 906 Certification of the Chief Executive Officer and the Chief Financial Officer.

- 40 -